Concepedia

M. Sinègre

MS

Statistics

Publications

6

Citations

172

H-Index

6

Active since

1998

Affiliations

Inserm(Current)

Sorbonne Paris Cité

Délégation Paris 5

Université Paris Cité

Assistance Publique – Hôpitaux de Paris

M. Sinègre is an author at Inserm specializing in pharmacy, market authorization processes, and drug approval processes.

Publications per year

1998–2015

6

Publications

6

Genetic background of Escherichia coli isolates from patients with spontaneous bacterial peritonitis: relationship with host factors and prognosis

F. Bert, Xavière Panhard, James R. Johnson et al. · Clinical Microbiology and Infection · 2008 · 49 citations · Full text

, , +16

Re-treatment with interferon alfa of patients with chronic hepatitis C

Wan‐Cheng Chow, Nathalie Boyer, M. Pouteau et al. · Hepatology · 1998 · 31 citations · Full text

, , +12

The “Temporary Recommendations for Use”: A dual-purpose regulatory framework for off-label drug use in France

Albane Degrassat-Théas, François C. Bocquet, M. Sinègre et al. · Health Policy · 2015 · 24 citations · Full text

, , +14

Biosimilar Versus Patented Erythropoietins: Learning from 5 Years of European and Japanese Experience

François Bocquet, Pascal Paubel, I. Fusier et al. · Applied Health Economics and Health Policy · 2014 · 23 citations

, , +7

Biosimilar Granulocyte Colony-Stimulating Factor Uptakes in the EU-5 Markets: A Descriptive Analysis

François Bocquet, Pascal Paubel, I. Fusier et al. · Applied Health Economics and Health Policy · 2014 · 23 citations

, , +6

1–5 of 6